$28.88
0.090.31%
Last update: Jun 5, 4:43 AM
Agios Pharmaceuticals Inc Earnings Estimates
AGIONASDAQ
M&A: Oscotec was acquired by Agios Pharmaceuticals (AGIO) on Monday, June 1, 2026
Agios Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AGIO
Agios Pharmaceuticals (AGIO) is scheduled to report Q2 earnings on July 30, 2026. Analysts estimate EPS of $-1.65 and quarterly revenue of $25.70M.
In the most recent quarter (Q1), Agios Pharmaceuticals reported EPS of $-1.69, beating estimates of $-1.79 by 0.06%. Revenue came in at $20.75M, exceeding the estimate of $13.83M by 0.50%.
Agios Pharmaceuticals has beaten EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Agios Pharmaceuticals has averaged an EPS surprise of 0.07% and a revenue surprise of 0.46%.
Earnings Date
Jul 30
EPS Estimate
$-1.650
Quarterly Revenue Estimate
$25.70M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$66.05M
Agios Pharmaceuticals Earnings History
Analyze the earnings history of Agios Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Agios Pharmaceuticals (AGIO) Earnings Per Share
The chart below shows Agios Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Agios Pharmaceuticals (AGIO) Revenue
The chart below shows Agios Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?
Agios Pharmaceuticals (AGIO) is scheduled to report earnings on July 30, 2026. The last reported earnings were for reported on April 29, 2026 for Q1.
What were the latest earnings per share (EPS) for Agios Pharmaceuticals (NASDAQ:AGIO)?
The Actual EPS was $-1.69, which beat the estimate of $-1.79.
What were Agios Pharmaceuticals’s (NASDAQ:AGIO) revenues?
The Actual Revenue was $20.75M, which beat the estimate of $13.83M.
